×
For best experience we recommend to activate Javascript in your browser.
Recombinant AXL (Mipasetamab Biosimilar) antibody
The Human Monoclonal anti-AXL (Mipasetamab Biosimilar) antibody (ABIN7675974) specifically detects AXL (Mipasetamab Biosimilar) in BLI, ELISA, FACS, Func and SPR.
The antibody is reactive with Human samples.
Catalog No. ABIN7675974
$346.15
Plus shipping costs $50.00
1 mg ABIN7581251
100 μg ABIN7675974
1 mg ABIN7581251
100 μg ABIN7675974
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant AXL (Mipasetamab Biosimilar) antibody (ABIN7675974)
Target
AXL (Mipasetamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for AXL (Mipasetamab Biosimilar) antibodies
Human
Clonality
All clonalities for AXL (Mipasetamab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for AXL (Mipasetamab Biosimilar) antibodies
This AXL (Mipasetamab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-AXL (Mipasetamab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-AXL / UFO Reference Antibody (mipasetamAb)
Characteristics
Anti-AXL / UFO Reference Antibody (mipasetamAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for AXL (Mipasetamab Biosimilar)
(hide)
Target
AXL (Mipasetamab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
P30530
Recently viewed
(hide)
You are here:
Homepage
Recombinant anti-AXL (Mipasetamab Biosimilar) antibody (ABIN7675974)
Chat with us , powered by LiveChat